Propofol infusion syndrome in severe COVID: a case report / Síndrome da infusão de propofol em COVID grave: relato de caso

Authors

DOI:

https://doi.org/10.26432/1809-3019.2022.67.015

Abstract

Introduction: Propofol Infusion Syndrome (PIS) consists of symptoms starting 48 hours following the infusion of a dose ≥ 5mg/kg/h and/or cumulative dose (CD) >240mg kg−1 of propofol. Objective: To present the clinical observations and evolution of a patient with severe involvement by COVID-19 and who presented PIS after continuous infusion of propofol. Case Report: Seven days after sedation with Propofol at 2,857 mg kg−1 h−1 and CD of 480 mg kg−1, a male patient diagnosed with SARS-COV2 presented with classic PIS signals. Conclusion: In the current context of the COVID-19 pandemic, PIS should always be considered in prolonged hospital stays, as should new sedation strategies.

 

Downloads

Download data is not yet available.

Downloads

Published

2022-10-20

Issue

V. 67 (2022): Jan/Dez

Section

RELATO DE CASO

License

Copyright (c) 2022 Affonso Jonathan Moro, Mauro Prado da Silva, Ana Lígia Bittencourt Yamamura, Thiago Ramos Grigio

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

DIREITOS AUTORAIS
Os manuscritos submetidos deverão ser acompanhados da Declaração de Transferência dos Direitos Autorais, assinada por todos os autores.

LICENÇA DA CREATIVE COMMONS – CC BY
A Revista "Arquivos Médicos" adota como padrão de atribuição de acesso aberto dos artigos, a licença CC-BY (Creative Commons). Essa licença permite que outras pessoas distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que o trabalho original seja corretamente citado. Os autores e fonte original devem ser citados.

https://creativecommons.org/licenses/by/4.0/